
SNWV Stock Forecast & Price Target
SNWV Analyst Ratings
Bulls say
SANUWAVE Health Inc. demonstrated significant financial growth in 2024, achieving a remarkable 60% year-over-year increase in revenue, totaling $32.6 million, primarily fueled by both system sales and consumables. The company also reported a substantial improvement in profitability, with adjusted EBITDA rising by 28 percentage points to reach +22%. While operating expenses increased by $1.1 million, largely due to non-cash stock-based compensation, the overall financial performance reflects a strong upward trend and positions SANUWAVE favorably within its industry.
Bears say
SANUWAVE Health has experienced a decline in applicator usage during the first quarter, a trend attributed to typical seasonal behavior as patients postpone treatments following the reset of annual insurance deductibles in January. Additionally, the company faces several challenges that may adversely affect its stock performance, including margin compression, reduced productivity among sales representatives, and competitive pressures. There are concerns over potential manufacturing setbacks that could further hinder operational efficiency and sales growth.
This aggregate rating is based on analysts' research of SANUWAVE Health Inc and is not a guaranteed prediction by Public.com or investment advice.
SNWV Analyst Forecast & Price Prediction
Start investing in SNWV
Order type
Buy in
Order amount
Est. shares
0 shares